Fig 3.
Mean concentration-time profiles of plasma dolutegravir and total radioactivity in blood and plasma after a single 20-mg (80-μCi) oral dose of [14C]dolutegravir to six healthy male subjects. (Inset) Data using log scale on the y axis.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.